Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis.
Wenfang GuoLetai YiBaochang ZhouMin-Hui LiPublished in: Nutrition journal (2020)
The glucose level of patients who are diabetic and obese/overweight can be improved by supplementation with chitosan for at least 13 weeks at 1.6-3 g per day. Additional clinical research data are needed to confirm the role of chitosan, particularly in regulating glycosylated hemoglobin and insulin.
Keyphrases
- type diabetes
- metabolic syndrome
- drug delivery
- wound healing
- systematic review
- end stage renal disease
- weight loss
- hyaluronic acid
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- adipose tissue
- glycemic control
- prognostic factors
- peritoneal dialysis
- meta analyses
- blood glucose
- electronic health record
- cardiovascular disease
- randomized controlled trial
- blood pressure
- uric acid
- machine learning
- cardiovascular risk factors
- big data
- body mass index